US regulator approves oral drug from Japan's Shionogi to prevent COVID-19
- Posted on June 1, 2026
- By Bing News
- 0 Views
- 1 min read
US regulator approves oral drug from Japan's Shionogi to prevent COVID-19
TOKYO, June 1 (Reuters) - Japan's Shionogi & Co said on Monday the U.S. Food and Drug Administration has approved its oral antiviral Ensitrelvir, commercially known as Xocova, for the preventive treatment of individuals who have been exposed to COVID-19. "XOCOVA is the first and only oral option clinically proven to help prevent symptomatic COVID-19 after exposure among study participants
